Recursion Prices $200 Million Stock Offering, Sanofi Options Drug Candidate
MT newswire2026/10/15 13:46Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
09:46 AM EDT, 10/15/2026 (MT Newswires) -- Recursion Pharmaceuticals (RXRX) said Thursday it priced an offering of 61.5 million shares at $3.25 each to raise gross proceeds of about $200 million. The offering is expected to close on Friday. Separately, Recursion said Sanofi has optioned the first drug candidate from the companies' research collaboration, triggering a $10 million milestone payment. Recursion said total upfront and milestone payments under the collaboration have reached $144 million and that it is eligible for more than $300 million of additional milestones and double-digit royalties on net sales, if approved. The drug candidate, aimed at inflammatory disease, is now in Sanofi's pipeline and is expected to enter phase 1 clinical trials in 2027, Recursion said. Recursion shares were 1.5% higher in Thursday trading, while Sanofi was up 1.6%.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
S&P 500 Index falls below 7,000 points
AiCoin•2026/11/20 19:30


TAKKT Cuts 2026 Outlook After Cyberattack Disrupts Operations
Bitget•2026/11/20 18:26

Crypto prices
MoreBitcoin
BTC
$58,598.41
-5.94%
Ethereum
ETH
$1,610.85
-8.94%
Tether USDt
USDT
$0.9987
-0.01%
BNB
BNB
$531.73
-9.28%
USDC
USDC
$0.9998
-0.00%
XRP
XRP
$0.8952
-7.35%
Solana
SOL
$68.12
-7.36%
TRON
TRX
$0.3010
-2.99%
Hyperliquid
HYPE
$60.82
-10.13%
Zcash
ZEC
$762.01
-15.46%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now